WinstonWınston
Back
Amplifon S.p.A. logo

Amplifon S.p.A.

AMP.MI
42
Medical - Distribution · Healthcare
Price
€11.88
+0.04 (+0.30%)
Market Cap
€2.61B
Exchange
Italian Stock Exchange
Winston Score
42
Winston is serious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Mixed
Growth
Weak
Cash Flow
Strong
Stability
Good
Valuation
Good
Dividends
Strong

Winston Score History

The full picture

Amplifon is an Italian company that sells and fits hearing aids to people who have trouble hearing. It runs a global network of retail hearing care clinics where trained specialists test customers' hearing and help them choose and adjust hearing devices. Amplifon is one of the largest hearing care retail networks in the world, operating under its own brand as well as local brands in various countries.

The company makes money primarily by selling hearing aids directly to consumers through its clinics, along with follow-up care and accessories. Amplifon operates in over 25 countries across Europe, the Americas, Asia-Pacific, and the Middle East, giving it broad geographic reach that few competitors can match at scale. Its main growth driver is the aging global population, which steadily increases demand for hearing care, though the business faces pressure from rising competition, including lower-cost online hearing aid sellers and direct-to-consumer devices that bypass traditional clinics.

Share count broadly stable

0.4% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 227.3M (2021) → 226.4M (2025)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
11.2%
Thin — 11.2% gross margin
Profit after running costs
Operating Margin
11.2%
Modest — 11.2% operating margin
Return on the money invested
ROCE
9.8%
Below par — 9.8% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-0.7%
Shrinking sales (-0.7% YoY)
Profit growth
EPS YoY
-48.2%
Earnings shrinking (-48.2% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is
EPS Consistency
0/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
284%
Turns 284% of profit into real cash
Spare cash per sale
FCF Margin
4.4%
Thin free cash flow (4.4%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.39
Conservative — low debt load (0.39)
Covers its interest
Interest Cover
3.49x
Tight — interest eats into profit (3.5x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
40.8x
Pricey — P/E 40.8

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year
P/E vs Forward
+28.7
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (40.8 → 12.1)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
2.45%
Moderate income — 2.45% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend record
Dividend Growth
+53.7%
Dividend growing fast (53.7% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial